Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesThe Effect of Anastrazole on Symptomatic Uterine Leiomyomata
Obstetrics and Gynecology, 10/12/07
Varelas, F., et al. - This was a prospective intervention study carried out in a university department of obstetrics and gynecology. Forty-one premenopausal women eligible for hysterectomy with 45 uterine leiomyomata were enrolled and treated with anastrazole 1 mg daily for three cycles of 28 days each. In premenopausal women, anastrazole reduces the size of uterine leiomyomata, improves symptomatology, and is generally well tolerated
Today in Women`s Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Impact and healthcare-seeking behaviour of premenstrual symptoms and dysmenorrhoea *TEST*
British Journal of Medical Practitioners, 12/17/09
Variable expression of cysteinyl leukotriene type I receptor splice variants in asthmatic females with different promoter haplotypes
BMC Immunology, 12/16/09
Major Study Finds Anti-HIV Gel Ineffective Among Women
National Institute of Allergy and Infectious Disease - News, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor